<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29454" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Staphylococcus saprophyticus Infection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ehlers</surname>
            <given-names>Sarah</given-names>
          </name>
          <aff>Kingman Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Merrill</surname>
            <given-names>Stefan A.</given-names>
          </name>
          <aff>Kingman Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah Ehlers declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stefan Merrill declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29454.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Staphylococcus saprophyticus is a Gram-positive bacterium that is a common cause of uncomplicated urinary tract infections, especially in young sexually active females. It is also responsible for complications including acute pyelonephritis, epididymitis, prostatitis, and urethritis. This activity illustrates the evaluation and management of Staphylococcus saprophyticus infections and describes the role of the interprofessional team in managing those with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the infections caused by S. saprophyticus.</p></list-item><list-item><p>Review the pathophysiology of S. saprophyticus infections.</p></list-item><list-item><p>Summarize the treatment options for S saprophyticus.</p></list-item><list-item><p>Outline the importance of improving care coordination among the interprofessional team in enhancing the delivery of care for those with this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29454&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29454">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29454.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Staphylococcus saprophyticus</italic> is a Gram-positive, coagulase-negative, non-hemolytic coccus that is a common cause of uncomplicated urinary tract infections (UTIs), particularly in young sexually active females. Less commonly, it is responsible for complications including acute pyelonephritis, urethritis, epididymitis, and prostatitis.<xref ref-type="bibr" rid="article-29454.r1">[1]</xref><xref ref-type="bibr" rid="article-29454.r2">[2]</xref></p>
        <p>An acute uncomplicated UTI is characterized by dysuria and frequency in an immunocompetent, non-pregnant adult female and is the most common bacterial infection in women. A complicated infection typically involves a patient that is immunocompromised, elderly, male, pregnant, diabetic, and/or with urologic abnormalities such as indwelling catheters or kidney disease.</p>
        <p><italic toggle="yes">S. saprophyticus </italic>can be differentiated from another coagulase-negative staphylococcus by its resistance to Novobiocin. Like other uropathogens, <italic toggle="yes">S. saprophyticus</italic> utilizes urease to produce ammonia. However, unlike many of these organisms, it cannot reduce nitrate.</p>
        <p><italic toggle="yes">S. saprophyticus</italic> is part of the normal human flora that colonizes the perineum, rectum, urethra, cervix, and gastrointestinal tract. It has also been found that <italic toggle="yes">S. saprophyticus </italic>is a common gastrointestinal flora in pigs and cows and thus may be transferred to humans through eating these respective foods.</p>
      </sec>
      <sec id="article-29454.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">S. saprophyticus </italic>is the second most common cause of community-acquired urinary tract infections, after <italic toggle="yes">Escherichia coli</italic>. In females ages 16 to 25, it causes up to 42% of all infections. Over 40% of all young, sexually active women contain <italic toggle="yes">S. saprophyticus</italic> as part of their normal genitourinary flora.<xref ref-type="bibr" rid="article-29454.r3">[3]</xref><xref ref-type="bibr" rid="article-29454.r4">[4]</xref><xref ref-type="bibr" rid="article-29454.r5">[5]</xref></p>
        <p>Patients with nosocomial UTIs, the elderly, pregnant patients, and those with urinary catheterization have an increased incidence of&#x000a0;<italic toggle="yes">S. saprophyticus</italic> colonization. Men have a lower incidence of <italic toggle="yes">S. saprophyticus</italic> infections.</p>
        <p>General risk factors for UTIs include the history of recurrent UTIs, female sex, recent sexual intercourse, pregnancy, neurogenic bladder, indwelling catheter, and benign prostatic hypertrophy.<xref ref-type="bibr" rid="article-29454.r6">[6]</xref><xref ref-type="bibr" rid="article-29454.r7">[7]</xref></p>
        <p><italic toggle="yes">S. saprophyticus</italic> is also a common culprit involved in polymicrobial UTIs. Polymicrobial infections are more likely to occur in patients that are immunocompromised, elderly, those who have diabetes, have indwelling catheters, HIV, and/or malignancies. Polymicrobial infections are less common in young, healthy, sexually active females.</p>
      </sec>
      <sec id="article-29454.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In the United States, urinary discomfort is a&#x000a0;common complaint in patients seeking medical attention. UTIs are one of the top 10 diagnoses made in emergency departments annually. Nearly half of all women will experience a UTI in their lifetime, and between 5% and 20% of&#x000a0;non-hospitalized patients, the infection will be due to <italic toggle="yes">S. saprophyticus. </italic>Despite highly successful treatment rates, up to 60% of all patients will experience a recurrent UTI within one year.</p>
      </sec>
      <sec id="article-29454.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bacterial colonization of the bladder and ureter epithelium by <italic toggle="yes">S. saprophyticus&#x000a0;</italic>occurs via several different types of adhesins. These include hemagglutinins with autolytic and adhesive properties, as well as surface-associated lipase that forms fimbria-like surface appendages, helping the bacteria to maintain tight adherence to these surfaces.</p>
        <p>It is suspected that the high survivability of <italic toggle="yes">S. saprophyticus</italic> inside the urinary tract is in part due to the adhesins anchored within the cell wall, allowing the organism to effectively adhere and colonize the uroepithelium, together with urease, which contributes to the persistent growth of the infection.</p>
        <p>Some strains of <italic toggle="yes">S. saprophyticus</italic> have the ability to create biofilms, increasing their virulence, especially in patients with catheters. Once biofilms have been produced, antibiotic resistance is exacerbated. In these cases, <italic toggle="yes">S. Saprophyticus</italic> may be resistant to vancomycin and only effectively treated via linezolid.</p>
      </sec>
      <sec id="article-29454.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The characteristic history of dysuria, urinary frequency, urinary urgency, and suprapubic pain will be common in symptomatic UTI patients. In those patients with pyelonephritis, back or flank pain, nausea, and fever or chills may also be present.</p>
        <p>Physical examination may reveal suprapubic tenderness, in 10% to 20% of cases, and should include urine specimen for analysis. However, in most cases of uncomplicated UTI, a physical examination is unremarkable. In complicated cases or pyelonephritis, patients may present with fever, tachycardia, and/or costovertebral angle tenderness.</p>
      </sec>
      <sec id="article-29454.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of <italic toggle="yes">S. saprophyticus</italic> requires a confirmatory urine culture. A positive culture is indicated by greater than 100,000 colony-forming units per mL, with a sensitivity and specificity of more than 90%.</p>
        <p>UTI, in general, may be diagnosed more cost-effectively with a urine dipstick alone. A dipstick that is positive for leukocytes esterase and/or nitrites is the most simplistic method of UTI diagnosis. In cases of negative dipstick results, and high clinical suspicion, a bacterial urine culture should also be obtained.<xref ref-type="bibr" rid="article-29454.r8">[8]</xref><xref ref-type="bibr" rid="article-29454.r9">[9]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>An adequate urine sample should be obtained from a mid-stream catch or straight catheterization, which more effectively avoids contamination.</p>
          </list-item>
        </list>
        <p>Imaging is not necessary for cases of uncomplicated UTIs. If renal pathology, such as pyelonephritis, is suspected a CT scan is the most sensitive modality for demonstrating complications such as hydronephrosis or renal abscess.</p>
      </sec>
      <sec id="article-29454.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment with outpatient antibiotics is indicated in symptomatic or complicated UTIs and pyelonephritis. It is important to take into consideration specific local resistance patterns when choosing appropriate antibiotic coverage.<xref ref-type="bibr" rid="article-29454.r10">[10]</xref></p>
        <p>The antibiotic of choice in uncomplicated <italic toggle="yes">S. saprophyticus</italic> UTIs is nitrofurantoin 100 mg orally twice daily for five days, or for seven days in complicated cases. Trimethoprim-sulfamethoxazole (TMP-SMX) 160 mg/800 mg by mouth twice daily for three days may be given alternatively in uncomplicated cases.</p>
        <p>Symptomatic treatment for pain and nausea should also be addressed.&#x000a0; Acute uncomplicated UTIs are unlikely to cause renal injury. Thus NSAIDs are a preferred analgesic. Pyridium may also be given to alleviate associated dysuria. Ondansetron or promethazine are commonly prescribed antiemetics. Most patients will notice symptomatic relief within 36 hours from antibiotic treatment alone.</p>
        <p>Patients who are hemodynamically unstable, have associated kidney injury, abscess formation, or emphysematous pyelonephritis, have failed outpatient treatment, have intractable nausea, vomiting, or pain, are unable to tolerate oral intake, or are unable to comply with medical treatment may require admission.</p>
      </sec>
      <sec id="article-29454.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other diagnoses include non-<italic toggle="yes">S. saprophyticu</italic>s UTI or cystitis, urethritis, pyelonephritis, or nephrolithiasis.</p>
      </sec>
      <sec id="article-29454.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The majority of <italic toggle="yes">S. saprophyticus</italic> infections can be adequately treated with antibiotics. However, if left untreated, they may progress to pyelonephritis. Untreated pyelonephritis may lead to further complications, such as renal insufficiency.</p>
      </sec>
      <sec id="article-29454.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>It is important to note that the diagnosis of UTI based on the combination of both leukocyte esterase and nitrites, will miss cases caused by <italic toggle="yes">S. saprophyticus</italic>. Like most other gram-positive uropathogens, <italic toggle="yes">S. saprophyticus</italic> does not reduce nitrate to nitrite.</p>
        <p><italic toggle="yes">S. saprophyticus</italic> has resistance to antibiotic regimes commonly prescribed and effective for <italic toggle="yes">E. coli</italic> induced UTIs, including ampicillin, ceftriaxone, cephalexin, and ciprofloxacin. In cases where UTI symptoms persist following treatment with one of the previously mentioned antibiotics, <italic toggle="yes">S. saprophyticus</italic> should be highly suspected.</p>
      </sec>
      <sec id="article-29454.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>UTIs are usually managed by the primary care provider, nurse practitioner, and internist. however, not all UTIs are due to gram-negative&#x000a0;organisms. In some cases, the organism may be S.Saprophyticus, which can only be identified following culture. While culture is not routine in all patients with a UTI, when the patient fails to improve, one must suspect a different organism and send the urine for culture.</p>
        <p>Treatment with outpatient antibiotics is indicated in symptomatic or complicated UTIs and pyelonephritis. It is important to take into consideration specific local resistance patterns when choosing appropriate antibiotic coverage.</p>
        <p>Patients who are hemodynamically unstable, have associated kidney injury, abscess formation, or emphysematous pyelonephritis, have failed outpatient treatment, have intractable nausea, vomiting, or pain, are unable to tolerate oral intake, or are unable to comply with medical treatment may require admission. These patients may need IV antibiotics and radiological studies to determine the extent of the infection.</p>
        <p>When treated promptly, most patients have good outcomes.<xref ref-type="bibr" rid="article-29454.r11">[11]</xref>&#x000a0;(Level V)</p>
      </sec>
      <sec id="article-29454.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29454&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29454">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/staphylococcus-saprophyticus-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29454">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29454/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29454">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29454.s14">
        <title>References</title>
        <ref id="article-29454.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Argemi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hansmann</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Prola</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pr&#x000e9;vost</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Coagulase-Negative Staphylococci Pathogenomics.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Mar</month>
            <day>11</day>
            <volume>20</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30862021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinault</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chabri&#x000e8;re</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Raoult</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fenollar</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Direct Identification of Pathogens in Urine by Use of a Specific Matrix-Assisted Laser Desorption Ionization-Time of Flight Spectrum Database.</article-title>
            <source>J Clin Microbiol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30700506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Natsis</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>671</fpage>
            <page-range>671-677</page-range>
            <pub-id pub-id-type="pmid">29882122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lala</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Minter</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Cystitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">29083726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hur</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bae</surname>
                <given-names>IG</given-names>
              </name>
            </person-group>
            <article-title>Staphylococcus saprophyticus Bacteremia originating from Urinary Tract Infections: A Case Report and Literature Review.</article-title>
            <source>Infect Chemother</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-9</page-range>
            <pub-id pub-id-type="pmid">27433385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores-Mireles</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Caparon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hultgren</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract infections: epidemiology, mechanisms of infection and treatment options.</article-title>
            <source>Nat Rev Microbiol</source>
            <year>2015</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>269</fpage>
            <page-range>269-84</page-range>
            <pub-id pub-id-type="pmid">25853778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Heilmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Coagulase-negative staphylococci.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>870</fpage>
            <page-range>870-926</page-range>
            <pub-id pub-id-type="pmid">25278577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stock</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].</article-title>
            <source>Med Monatsschr Pharm</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>242</fpage>
            <page-range>242-8</page-range>
            <pub-id pub-id-type="pmid">25065160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical aspects of antimicrobial prophylaxis for invasive urological procedures.</article-title>
            <source>J Chemother</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>26 Suppl 1</volume>
            <fpage>S1</fpage>
            <page-range>S1-S13</page-range>
            <pub-id pub-id-type="pmid">25245706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Widerstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wistr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;stedt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monsen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-20</page-range>
            <pub-id pub-id-type="pmid">21533877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29454.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stuart</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Milburn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diagre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>248</fpage>
            <page-range>248-52</page-range>
            <pub-id pub-id-type="pmid">21295951</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
